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MCP-induced protein 1 deubiquitinates
TRAF proteins and negatively regulates JNK
and NF-B signaling
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Qinglin Yang,4 Pappachan E. Kolattukudy,1 and Mingui Fu1,2,3
1Burnett

School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816
of Basic Medical Science and 3Shock Trauma Research Center, School of Medicine, University of Missouri–Kansas
City, Kansas City, MO 64108
4Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35242

The Journal of Experimental Medicine
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The intensity and duration of macrophage-mediated inflammatory responses are controlled
by proteins that modulate inflammatory signaling pathways. MCPIP1 (monocyte chemotactic protein–induced protein 1), a recently identified CCCH Zn finger–containing protein,
plays an essential role in controlling macrophage-mediated inflammatory responses. However, its mechanism of action is poorly understood. In this study, we show that MCPIP1
negatively regulates c-Jun N-terminal kinase (JNK) and NF-B activity by removing ubiquitin moieties from proteins, including TRAF2, TRAF3, and TRAF6. MCPIP1-deficient mice
spontaneously developed fatal inflammatory syndrome. Macrophages and splenocytes from
MCPIP1/ mice showed elevated expression of inflammatory gene expression, increased
JNK and IB kinase activation, and increased polyubiquitination of TNF receptor–associated
factors. In vitro assays directly demonstrated the deubiquitinating activity of purified
MCPIP1. Sequence analysis together with serial mutagenesis defined a deubiquitinating
enzyme domain and a ubiquitin association domain in MCPIP1. Our results indicate that
MCPIP1 is a critical modulator of inflammatory signaling.
CORRESPONDENCE
Mingui Fu:
fum@umkc.edu
Abbreviations used: AFC,
7-amino-4-trifluoromethyl
coumarin; BAP, bacterial alkaline
phosphatase; BMDM, BMderived macrophage; CCR,
C-terminal conserved region;
DUB, deubiquitinating enzyme;
HA, hemagglutinin; IKK, IB
kinase; IsoT, isopeptidase T;
JNK, c-Jun N-terminal kinase;
MEF, mouse embryonic fibroblast; mRNA, messenger RNA;
NCR, N-terminal conserved
region; NEM, N-ethylmaleimide;
NEMO, NF-B essential modulator; QPCR, quantitative PCR;
RIP, receptor-interacting protein; RIPA, radioimmunoprecipitation assay; TRAF, TNF
receptor–associated factor; TTP,
tristetraprolin; UBA, ubiquitin
association domain; UCH, ubiquitin C-terminal hydrolase; UTR,
untranslated region; WCE, whole
cell extract; ZF, Zn finger domain.

Inflammation is an important component of innate immunity and the host response to pathogens (Henneke and Golenbock, 2004). In response
to infection with virus or bacteria, macrophages
produce cytokines such as TNF and IL-1, which
initiate the inflammatory response (Dinarello,
2005). The inflammatory response must be precisely controlled at multiple levels, as uncontrolled
inflammation does not benefit organisms but
instead causes tissue impairment and drives
autoimmunity, septic shock, and inflammationassociated malignancy (Karin and Greten, 2005).
TNF receptor–associated factors (TRAFs)
play a central role in the TNF-, IL-1–, and LPSinduced signaling pathways (Lee et al., 1997).
Binding of LPS to TLR4 (Toll-like receptor 4)
triggers the recruitment of MyD88 and IRAK1/4,
which then recruits TRAF6 and triggers downstream signaling (Dong et al., 2006). Downstream of TRAF6, TAK1 (TGF-–activated
kinase 1) and the adaptor proteins TAB2 and
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TAB3 mediate the activation of the IB kinase
(IKK) complex (Sato et al., 2005). TAK1 has
also been reported to be important for TNFmediated NF-B activation (Takaesu et al.,
2003). Binding of IL-1 to the IL-1R also triggers the recruitment of the adaptor protein
MyD88 to the receptor. MyD88 then recruits
the kinases IRAK1 and IRAK4, which play an
essential role in the recruitment of TRAF6,
triggering its oligomerization and autoubiquitination via Lys 63 (K63)–linked ubiquitin
chains (Deng et al., 2000). Binding of TNF to
TNF-R1 results in the recruitment of the
adaptor protein TRADD (TNF receptor type 1–
associated death domain protein), which
subsequently recruits a signaling complex consisting of TRAF2, TRAF5, and RIP1 (Tada
et al., 2001). TRAF2 or RIP1 then plays a role
© 2010 Liang et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after
the publication date (see http://www.rupress.org/terms). After six months it is
available under a Creative Commons License (Attribution–Noncommercial–Share
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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in the recruitment of the IKK complex to TNF-R1, leading
to oligomerization and activation. In addition to NF-B activation, TNF, IL-1, and LPS are potent activators of c-Jun
N-terminal kinase (JNK), which regulates the activation of
AP-1 transcription factors, including c-Jun and ATF-2 (Song
et al., 1997).
JNK and NF-B signaling mediate a wide spectrum of
cellular responses, including infections, inflammation, and
apoptosis (Muzio et al., 1998). Inappropriate regulation of
JNK and NF-B signaling is involved in a wide range of
human diseases, including cancer, neurodegenerative disorders, arthritis, asthma, and chronic inflammation (Karin and
Greten, 2005). Thus, JNK and NF-B activation must be
tightly regulated to maintain transient activation to prevent
inflammation-induced tissue damage or malignancy associated with persistent JNK and NF-B activation. Ubiquitination plays important regulatory roles in several steps of JNK
and NF-B signaling events and thus is an important target
for several negative regulators of JNK and NF-B. The cylindromatosis tumor suppressor CYLD has been shown to
inhibit both JNK and NF-B signaling mediated by TNF,
LPS, CD40, and IL-1 by cleaving K63-linked ubiquitin
chains on TRAF2, TRAF6, and IKK- (Kovalenko et al.,
2003; Regamey et al., 2003; Trompouki et al., 2003; Reiley
et al., 2004). Another deubiquitinating enzyme (DUB) that
is an important regulator of NF-B is A20, which is a transcriptional target of NF-B (Wertz et al., 2004). A20-deficient
mice develop severe inflammation and cachexia and die prematurely (Lee et al., 2000).
MCPIP1 (monocyte chemotactic protein [MCP]–induced
protein 1; also known as ZC3H12A) is a recently identified
gene in human peripheral blood monocytes treated with
MCP-1 (Zhou et al., 2006; Liang et al., 2008b). The gene
undergoes rapid and potent transcription induction upon
stimulation with proinflammatory molecules such as TNF,
MCP-1, IL-1, and LPS (Liang et al., 2008a,b; Matsushita
et al., 2009; Skalniak et al., 2009; Kasza et al., 2010). Further
studies showed that MCPIP1 plays an important role in
both physiological and pathological processes related to inflammation. In the experiments on cultured cells, MCPIP1
was proved to be a negative regulator of macrophage activation (Liang et al., 2008b). In a recent study on mice,
MCPIP1 deficiency led to a complex phenotype including
severe anemia, autoimmune response, and severe inflammatory response, and most mice died within 12 wk of birth
(Matsushita et al., 2009). The underlying mechanism of action of MCPIP1 is poorly understood, but it was suggested
that it may control messenger RNA (mRNA) stability of
a set of inflammatory genes by functioning as an RNase
(Matsushita et al., 2009). In this study, we report that
MCPIP1 acts as a deubiquitinase to negatively regulate JNK
and NF-B signaling by targeting TRAFs. These results
suggest that MCPIP1 may critically control inflammation
and immune response by multiple mechanisms and would
be a potential therapeutic target for treatment of human inflammatory diseases.
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RESULTS
Disruption of MCPIP1 leads to severe inflammatory response
and premature death in mice
Previously, we have identified MCPIP1 as a negative regulator of LPS- and cytokine-induced macrophage activation
in vitro probably by antagonizing the NF-B signaling pathway
(Liang et al., 2008b). To further investigate the physiological
function of MCPIP1 in vivo, we generated Mcpip1/ mice
by homologous recombination in embryonic stem cells from
C57BL/6 background mice. We targeted mouse Mcpip1
exons 4 and 5 and most of 6 with a LacZ-neomycin cassette
in embryonic stem cells established from C57BL/6 mice and
established Mcpip1/ mice in pure C57BL/6 background
(Fig. 1 a). We confirmed homologous recombination of the
Mcpip1 locus by Southern blot analysis (unpublished data).
The lack of MCPIP1 protein in Mcpip1/ mice was confirmed by immunoblotting (Fig. 1 b). Mcpip1/ mice were
born from interbred Mcpip1+/ mice at the expected Mendelian ratios and looked normal at birth. Similar to the findings
in a recent study (Matsushita et al., 2009), Mcpip1/ mice
showed growth retardation after weaning (Fig. 1 c), severe
splenomegaly (Fig. 1 d, top), and lymphadenopathy (Fig. 1 d,
bottom) and died prematurely (Fig. 1 e). Meanwhile, serum
TNF and MCP-1 levels in Mcpip1/ mice were >2.5 times
of those in Mcpip1+/+ mice (Fig. 1 f).To examine the function
of MCPIP1 in macrophages, we isolated BM-derived macrophages (BMDMs) from Mcpip1+/+ and Mcpip1/ mice.
MCPIP1-deficient BMDMs secreted a greater amount of
proinflammatory cytokines TNF, IL-1, IL-6, or MCP-1
both in normal culture conditions and in response to LPS
stimulation as compared with WT BMDMs (Fig. 1 g). Realtime RT-PCR showed that the mRNA levels of inflammatory cytokines, including TNF, IL-6, and IL-1, were also
increased in BMDMs from Mcpip1/ mice in response to
LPS stimulation (Fig. 1 h). As RNA blotting detected abundant mRNA of Mcpip1 in spleen, thymus, lung, and intestine
(Fig. S1), we also isolated the total RNA from these tissues of
both Mcpip1+/+ and Mcpip1/ mice. As expected, the mRNA
expression of inflammatory cytokines, including TNF, IL-1,
IL-6, and iNOS (inducible nitric oxide synthase), was significantly up-regulated in the intestine, lung, and thymus from
Mcpip1/ mice compared with Mcpip1+/+ mice (Fig. S2).
Collectively, these results further indicate that MCPIP1 is a
critical modulator of macrophage inflammation in vivo and
may play a key role in controlling inflammatory response and
immune homeostasis.
Effect of MCPIP1 on LPS or IL-1–induced JNK and NF-B
signaling activation
To understand the mechanisms underlying the inflammatory
phenotypes of Mcpip1-null mice, we first isolated the protein
extracts of lungs from both Mcpip1+/+ and Mcpip1/ mice. As
shown in Fig. 2 a, the JNK phosphorylation was markedly increased in lung tissue from Mcpip1/ mice compared with
that from Mcpip1+/+ mice. Phospho–IKK- and phosphoIB were moderately increased, whereas total IB protein
MCPIP1 deubiquitinates TRAFs | Liang et al.
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Figure 1. Disruption of MCPIP1 leads to severe inflammatory response and premature death in mice. (a) The structure of the mouse Mcpip1
gene is shown. The targeting strategy deleted exons 4 and 5 and most of 6, which encode the most part of the MCPIP1 protein, including the ZF and Pro
domains. (b) Proteins extracted from the intestine, lung, and spleen of mice were analyzed by immunoblotting with MCPIP1-specific antibody. The same
membrane was probed with antiactin to show equal loading. The experiment was performed on three independent sets of animals. (c and d) Gross
appearance of Mcpip1+/+ and Mcpip1/ mice (6–8-wk-old male; c), as well as spleens (d, top) and LNs (d, bottom) from these mice. The ruler (left margin)
indicates size in centimeters. Three independent sets of animals showed similar results. (e) Survival rate of Mcpip1+/+ and Mcpip1/ mice (n = 19).
(f) ELISA was used to measure serum cytokine levels in WT and KO mice. Data are presented as mean ± SD (n = 6; *, P < 0.05; **, P < 0.01 vs. WT group).
(g) BMDMs from WT (open bars) and KO (closed bars) mice were stimulated with PBS or 100 ng/ml LPS for 5 h. ELISA was used to measure cytokine levels
in cultured medium. Data are presented as mean ± SD (n = 3; *, P < 0.05; **, P < 0.01 vs. WT group). Results are representative of two independent experiments. (h) Total RNA isolated from BMDMs stimulated with LPS for the indicated time periods was reverse transcribed and analyzed by QPCR with genespecific primers as indicated. Data are presented as mean ± SD (n = 3). Student’s t test was performed. The experiment was performed on two
independent sets of animals with triplicate measurements.

was decreased in the lung from Mcpip1/ mice compared
with those from Mcpip1+/+ mice. These results suggested that
both JNK and NF-B signaling were constitutively activated
in the lung of Mcpip1/ mice. Second, we examined LPSinduced JNK and NF-B signaling activation in BMDMs
from Mcpip1+/+ or Mcpip1/ mice. As shown in Fig. 2 b,
LPS-induced phosphorylation of JNK, ERK1/2, and IKK-
was significantly enhanced in Mcpip1/ BMDMs compared
with Mcpip1+/+ BMDMs.These results suggest that Mcpip1 is
essential for the down-regulation of JNK and NF-B activation upon LPS stimulation. To further confirm the effect of
MCPIP1 on LPS-stimulated JNK and NF-B signaling activation, we transfected MCPIP1 and control vectors into
JEM VOL. 207, December 20, 2010

Raw264.7 cells.Transfected cells were stimulated by 100 ng/ml
LPS for 0, 5, 15, and 30 min after 24 h of quiescence. The activation of signaling proteins in the JNK and NF-B signaling
pathways was detected by immunoblotting with phosphospecific antibodies. As shown in Fig. 2 c, MCPIP1 expression
completely blocked LPS-induced JNK phosphorylation and
partially blocked ERK1/2, p38, and IKK- phosphorylation.
These changes were not caused by protein degradation because
JNK, ERK1/2, p38, and IKK- protein levels were not affected
by MCPIP1 overexpression. These results suggest that MCPIP1
expression significantly inhibits LPS-induced JNK activation
but moderately affects ERK1/2, p38, and IKK activation.
2961

Figure 2. Effect of MCPIP1 on LPS- and IL-1–
induced JNK and NF-B activation. (a) Proteins extracted from the lung of three pairs of Mcpip1+/+ and
Mcpip1/ mice were analyzed by immunoblot with the
indicated antibodies. Results are representative of three
independent experiments. (b) BMDMs from Mcpip1/ or
Mcpip1+/+ mice were quiescent for 16 h and then stimulated with 100 ng/ml LPS for the indicated time periods.
WCEs were subjected to immunoblot analysis with antibodies as indicated. Similar results were seen in three independent experiments. (c) Raw264.7 cells were transfected
with pcDNA3 (vector) or pHA-MCPIP1. After 24 h, the
transfected cells were quiescent for 16 h and then stimulated with 100 ng/ml LPS for the indicated time periods.
WCEs were subjected to immunoblot analysis with antibodies as indicated. Nuclear fractions (Nuc.) were prepared
and subjected to immunoblot analysis using p65-specific
antibody. Results are representative of at least three independent experiments. (d) MEFs from Mcpip1/ or
Mcpip1+/+ mice were quiescent for 16 h and stimulated
with 10 ng/ml IL-1 for the indicated time periods. WCEs
were subjected to immunoblot analysis with antibodies as
indicated. (e) HepG2 cells were transfected with pcDNA3
(vector) or pHA-MCPIP1. After 24 h, the transfected cells
were quiescent for 16 h and then stimulated with 10 ng/ml
IL-1 for the indicated times. WCEs were subjected to
immunoblot analysis with antibodies as indicated.

However, Mcpip1 deficiency did not significantly
affect the activation of ERK1/2 and IKK-. To
further confirm the effect of MCPIP1 on IL-1–
stimulated JNK and NF-B signaling activation,
we transfected MCPIP1 and control vectors into
HepG2 cells, a cell type which is easier for transfection and responds efficiently to IL-1 stimulation.
Consistently, MCPIP1 expression significantly
suppressed IL-1–induced JNK phosphorylation
but did not affect ERK1/2, p38, and IKK-
phosphorylation.These results suggest that MCPIP1
is essential to down-regulate IL-1–induced
JNK signaling but not critical in IL-1–induced
ERK1/2, p38, and NF-B signaling.

Consistently, MCPIP1 expression also reduced LPS-induced
p65 nuclear translocation in Raw264.7 cells.
To examine the function of MCPIP1 in IL-1R signaling,
we analyzed the effect of Mcpip1 deficiency on IL-1–
stimulated activation of JNK and NF-B signaling in primary
mouse embryonic fibroblasts (MEFs), a cell type which responds efficiently to IL-1 stimulation. As shown in Fig. 2 d,
Mcpip1-deficient MEFs showed increased activation of JNK
in response to IL-1 stimulation, suggesting that MCPIP1 is
essential to down-regulate IL-1–induced JNK activation.
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MCPIP1 inhibits NF-B– and AP-1–
but not STAT-dependent gene activation
Next, we examined the effect of MCPIP1 on
NF-B–, AP-1–, or STAT-dependent gene activation. Raw264.7 cells were transiently transfected with a luciferase reporter construct, NF-B–TK-Luc,
AP-1–TK-Luc, or GAS-TK-Luc, together with increasing
doses of hemagglutinin (HA)-tagged MCPIP1. After overnight of quiescence, cells were either left untreated or treated
with LPS or TNF or IFN- plus LPS for 24 h, followed by
luciferase assays. As shown in Fig. 3 (a and b), MCPIP1 overexpression did not significantly affect the basal activity of
NF-B reporter and AP-1 reporter. However, overexpression
of MCPIP1 significantly inhibited LPS-induced NF-B reporter activation and TNF-induced AP-1 reporter activation
MCPIP1 deubiquitinates TRAFs | Liang et al.
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in a concentration-dependent manner. MCPIP1 expression
did not affect LPS- and IFN-–induced STAT-dependent gene
activation (Fig. 3 c).The overexpression of MCPIP1 in the transfected cells was confirmed by immunoblotting with HA antibody (Fig. 3 c, bottom). These results further support the idea
that MCPIP1 selectively represses LPS- and cytokine-initiated

Figure 3. Overexpression of MCPIP1 inhibits NF-B and AP-1 but
not STAT activation. (a–c) Raw264.7 cells were cotransfected AP-1–
TK-Luc (a), NF-B–TK-Luc (b), or GAS-TK-Luc (c) with increasing amounts of
pHA-MCPIP1 (0, 25, 50, and 100 ng/well, as indicated by wedges) using
Fugene6 (Roche). After quiescence for 16 h, cells were treated with or
without 10 ng/ml TNF (a), 100 ng/ml LPS (b), or IFN- plus LPS (c).
Reporter gene activity was analyzed 24 h later. The data are presented as
mean ± SD (n = 4; *, P < 0.01 vs. stimulated without MCPIP1 transfection
group). Analysis of variance with Bonferroni correction was performed.
Results are representative of at least three independent experiments.
Immunoblotting shows expression of HA-MCPIP1. -Actin served as a
loading control. (d) Raw264.7 cells were transfected with pEGFP-N1 or
pMCPIP1-GFP plasmids. 16 h later, the transfected cells were treated with
or without 1 mg/ml LPS for 8 h. mRNA was labeled and hybridized to the
44K Agilent Mouse Oligo Microarray. 30% of LPS-induced genes were
affected by the expression of MCPIP1. (e) 26 selected genes that are induced by LPS >10-fold (some unaffected by MCPIP1 and others affected
by MCPIP1) were clustered and presented as a heat map. Red is represented as high expression, whereas black means low expression. The expression of MCPIP1-GFP (93 kD) was detected by immunoblotting with
anti-MCPIP1 and shown at the bottom.
JEM VOL. 207, December 20, 2010

NF-B and JNK–AP-1 signaling pathways but does not
affect the JAK–STAT signaling pathway.
NF-B and AP-1 individually or coordinately regulate a
large set of inflammatory gene expressions. To examine the
whole gene expression changes caused by MCPIP1 expression in an unbiased way, we performed microarray analysis.
A macrophage cell line Raw264.7 was transfected with GFP
or MCPIP1-GFP constructs. These cells were treated with or
without LPS for 8 h before mRNA harvest. Overall, LPS
treatment induced 1,783 genes by more than threefold compared with the untreated cells. Among the 1,783 of LPSinduced genes, 30% of them were affected by overexpression
of MCPIP1 (Fig. 3 d). Among the MCPIP1-affected genes,
85% of the genes were repressed by MCPIP1, and 15% of
the genes were up-regulated by MCPIP1. The 26 genes upregulated by >10-fold in LPS-treated cells were selected and
shown in Fig. 3 e as a heat map. Consistent with our previous
results (Liang et al., 2008b), the inflammatory genes TNF,
IL-1, IL-6, and MCP-1, whose transcription is controlled by
NF-B and JNK signaling, were significantly repressed by
MCPIP1. Overexpression of MCPIP1 was confirmed by
immunoblotting with MCPIP1 antibody (Fig. 3 e, bottom).
These results further support the idea that MCPIP1 may control a set of the inflammatory gene expressions and prevent
inflammatory responses in vivo.
MCPIP1 acts as a deubiquitinase
Recent studies have identified a critical role for ubiquitination in JNK and NF-B signaling (for review see Skaug et al.,
2009). To understand how MCPIP1 regulates JNK and NF-B
signaling, we first tested the effect of MCPIP1 expression
on global protein ubiquitination.To facilitate the detection of
ubiquitin conjugates, HEK293 cells were transfected with
HA-tagged ubiquitin and MCPIP1 or tristetraprolin (TTP),
another well-studied CCCH Zn finger protein. Immuno
blotting of whole cell lysates with HA antibody revealed that
cells expressing MCPIP1 contained far fewer ubiquitinated
proteins than cells not expressing MCPIP1 (Fig. 4 a). Interestingly, TTP also reduced protein ubiquitination, although less
potently than MCPIP1. These results indicate that MCPIP1
promotes deubiquitination, although it remains uncertain
whether MCPIP1 has intrinsic deubiquitinating activity or
regulates ubiquitination indirectly via other cellular proteins.
To determine whether MCPIP1 has deubiquitinating activity,
we purified Flag-tagged MCPIP1 from HEK293 cells. The
purity of the purified protein was confirmed by Coomassie
brilliant blue staining and immunoblotting analysis (Fig. 4 b).
To test whether MCPIP1 cleaves K48- or K63-linked poly
ubiquitin, we incubated MCPIP1 with K48- or K63-linked
pentaubiquitin. Isopeptidase T (IsoT), a well-known deubiquitinase (Hadari et al., 1992), was also included as a positive
control. As shown in Fig. 4 c, MCPIP1 cleaved K48-linked
polyubiquitin chain into monomers, as did IsoT. MCPIP1
cleaved K63-linked polyubiquitin chain into different oligomers, which suggests incomplete cleavage. To exclude the
possibility that this deubiquitinating activity is caused by trace
2963

DUB contamination from 3xFlag elution buffer or immunoprecipitation procedures, we incubated hexaubiquitin chain
with 3xFlag elution buffer, immunoprecipitants from empty
vector–transfected cells, or Flag-p53. No cleavage was detected in these reactions (Fig. 4 d). Next, we incubated FlagMCPIP1 protein with K63-linked polyubiquitin chains of
different lengths, followed by immunoblotting detection. As
shown in Fig. 4 e, MCPIP1 cleaved polyubiquitin with a preference for high molecular polyubiquitin chains like hexa
ubiquitin or octaubiquitin. It showed little cleavage toward the

linear diubiquitins. Further experiments confirmed that
MCPIP1 cleaved K63-linked octaubiquitin chains in doseand time-dependent manners (Fig. 4 f). Furthermore, we observed that the activity of MCPIP1 to cleave polyubiquitin
was completely blocked by N-ethylmaleimide (NEM), a Cys
protease inhibitor (Fig. 4 g). Interestingly, the deubiquitinating activity of MCPIP1 was also completely abolished by
Zn2+ and Mn2+ but was not affected by Mg2+, Ca2+, and
EDTA (Fig. 4 h). To further quantitatively assess the deubiquitinating activity for MCPIP1, we incubated purified

Figure 4. MCPIP1 acts as a deubiquitinase. (a) HEK293 cells were cotransfected with HA-ubiquitin (Ub) and/or MCPIP1-GFP and/or Flag-TTP. 36 h later,
the ubiquitinated proteins in denatured cell lysates were detected by immunoblotting (IB) with HA-specific antibody. The expression of MCPIP1-GFP, Flag-TTP,
and actin was also detected by immunoblotting with MCPIP1, Flag, and actin-specific antibodies. Results are representative of at least three independent
experiments. (b) Flag-tagged MCPIP1 was immunoprecipitated from transfected HEK293 cells. The purified protein was examined by Coomassie blue staining
(Coomas.) and immunoblotting using Flag-specific antibody. (c) 1 µg of purified Flag-MCPIP1 was incubated with K63- or K48-linked pentaubiquitin chains
(Ub5) at 37°C for 16 h. Reactions were analyzed by immunoblotting with ubiquitin-specific antibody. Recombinant IsoT was used as a positive control. The
blot below the dashed lines had a longer exposure time than the blot above the dashed lines. Long exposure means 2–5 min exposure of the same film.
(d) Flag-MCPIP1, 3xFlag elution buffer, immunoprecipitants from empty vector–transfected cells, or Flag-p53 was incubated with K63-linked Ub6 at 37°C for
16 h. Reactions were analyzed by immunoblotting with ubiquitin-specific antibody. HMUb, high molecular weight ubiquitin. (e) In vitro deubiquitination
assays using purified Flag-MCPIP1 showing cleavage of high molecular K63-linked polyubiquitin chains (Ub5–8) but not low molecular polyubiquitin chains
(Ub2–4) or linear Ub2. (f) In vitro deubiquitination showing that MCPIP1 cleaved Ub8 in time- and dose-dependent manners. (g and h) MCPIP1 deubiquitinase
activity was assessed in the presence of the Cys protease inhibitor NEM, 10 mmol/l Zn2+, 10 mmol/l Mn2+, 50 mmol/l EDTA, 10 mmol/l Mg2+, or 10 mmol/l Ca2+.
Data in b–h are representative of at least three independent experiments. (i) 0.5, 1, and 2 µg (indicated by wedge) of purified Flag-MCPIP1 was incubated with
80 µM ubiquitin-AFC at 23°C for 5 min. The protease activity was determined by the release of fluorescent AFC (ex: 400 nm, em: 505 nm). 1 µg IsoT was used
as a positive control. Values were represented as relative fluorescent units (RFU; mean ± SD; n = 3; *, P < 0.001 vs. none group). Two-way analysis of variance
with Bonferroni correction was performed. The top shows a fluorescent image of the reactions in a 96-well plate. Results are representative of two independent experiments. (j) The global cellular ubiquitinated proteins in the splenocytes from Mcpip1+/+ and Mcpip1/ mice were detected by immunoblotting with
ubiquitin-specific antibody. Actin was detected and served as a loading control. Three independent experiments showed similar results.
2964
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MCPIP1 with ubiquitin–7-amino-4-trifluoromethylcoumarin (AFC) in an in vitro deubiquitination assay. Purified
MCPIP1 cleaved ubiquitin-AFC in a dose-dependent manner
with less potency compared with IsoT (Fig. 4 i). Moreover,
the global ubiquitinated protein level in the splenocytes from
Mcpip1/ mice was much higher than that from Mcpip1+/+
mice (Fig. 4 j). Collectively, these results indicate that MCPIP1
has intrinsic deubiquitinating activity and suggest that MCPIP1
may regulate JNK and NF-B signaling through deubiquitination in vivo.
MCPIP1 deubiquitinase targets to TRAFs
TRAFs have been shown to function as ubiquitin ligases that
catalyze the synthesis of K63-linked polyubiquitin chains.
However, this type of ubiquitination, which occurs early during
a cellular response and does not target protein degradation,
is important for signal transduction (Lomaga et al., 1999;
Lamothe et al., 2007). Stimulus-dependent autoubiquitination
of TRAF2 and TRAF6 activates the TAK1, which is critical in the activation of NF-B and MAPK (mitogenactivated protein kinase). To examine whether MCPIP1
targets the key components in the JNK and NF-B signaling
pathways, we transfected HA-ubiquitin with MCPIP1-GFP
or Flag-TTP into HEK293 cells. After 2 h of TNF treatment,
both TRAF2 and TRAF6 in the denatured cell lysates were
immunoprecipitated by TRAF2 or TRAF6 antibodies. The
ubiquitinated TRAF2 or TRAF6 in the immunoprecipitates
was further detected by immunoblotting with HA antibody.
As shown in Fig. 5 a, both TRAF2 and TRAF6 were ubiquitinated upon HA-ubiquitin overexpression. Intriguingly,
MCPIP1 expression markedly decreased TRAF2 and TRAF6
ubiquitination. TTP, another CCCH Zn finger protein, did
not affect TRAF2 ubiquitination but seemed to also reduce
TRAF6 ubiquitination. We also observed the effect of
MCPIP1 on the ubiquitination of receptor-interacting protein (RIP) and NF-B essential modulator (NEMO). Interestingly, MCPIP1 similarly decreased the RIP ubiquitination
but showed less effect on NEMO ubiquitination. Because
RIP ubiquitination is dependent on TRAF2 signaling, the effect of MCPIP1 on RIP ubiquitination may be indirect.
To further confirm the effect of MCPIP1 on TRAF ubiquitination, we cotransfected Flag-TRAF2 or Flag-TRAF3 with
HA-ubiquitin into HEK293 cells. The ubiquitinated TRAF2
or TRAF3 in the denatured cell lysates was immunoprecipitated by Flag antibody and further detected by immunoblotting with HA antibody. Polyubiquitination of both proteins
was indeed observed. Transfection of MCPIP1 together with
TRAF2 or TRAF3 resulted in a drastic decrease in the ubiquitinated forms of the two proteins (Fig. 5 b). Next, we tested
whether MCPIP1 also affects the K48-linked ubiquitination
of IB. We transfected HA-ubiquitin with Flag-MCPIP1
into HEK293 cells. After 24 h, the transfected cells were
treated with TNF and MG132 for 2 h to prevent the degradation of cellular proteins mediated by K48-linked poly
ubiquitin chain. IB in the denatured cell lysates was
immunoprecipitated by IB antibody. The ubiquitinated
JEM VOL. 207, December 20, 2010

IB in the immunoprecipitates was further detected by
immunoblotting with HA antibody. As shown in Fig. 5 c,
MCPIP1 expression also dramatically decreased IB ubiquitination. To further examine whether MCPIP1 physiologically regulates TRAF ubiquitination in vivo, TRAF2 in the
spleen of Mcpip1/ and Mcpip1+/+ mice was immunoprecipitated by TRAF2 antibody. The ubiquitinated TRAF2 in the
immunoprecipitates was detected by immunoblotting with
ubiquitin antibody. As shown in Fig. 5 d, TRAF2 was constitutively ubiquitinated in Mcpip1/ mice but not in Mcpip1+/+
mice (Fig. 5 d).To further examine the effect of Mcpip1 deficiency on TRAF ubiquitination in response to LPS stimulation,
we isolated splenocytes from Mcpip1+/+ mice and Mcpip1/
mice. The in vitro cultured splenocytes were stimulated with
100 ng/ml LPS for 30 min. TRAF2, TRAF3, TRAF6, and
RIP were immunoprecipitated with the respective individual
antibody. The polyubiquitinated TRAF2, TRAF3, TRAF6, and
RIP in the immunoprecipitates were detected by immuno
blotting with ubiquitin antibody. As shown in Fig. 5 e,
Mcpip1 deficiency led to a drastic increase in both basal and
LPS-induced ubiquitination of TRAF2,TRAF3, and TRAF6
but not RIP in splenocytes. To further examine whether
MCPIP1 directly cleaves polyubiquitin chain from ubiquitinated TRAF2 and TRAF3, we transfected Flag-TRAF2
or Flag-TRAF3 with HA-ubiquitin into HEK293 cells.
The transfected cells were stimulated with TNF for 15 min
before harvest. The cellular ubiquitinated TRAF2 was purified by anti-Flag gel and washed with 3xFlag buffer and
incubated with 0, 0.5, and 2 µg Flag-MCPIP1, followed by
immunoblotting with HA antibody. As shown in Fig. 5 f, the
ubiquitin moieties on TRAF2 can be removed by MCPIP1
in a dose-dependent manner. Similarly, the ubiquitin moieties on TRAF3 can also be removed directly by MCPIP1
(Fig. 5 g). Flag–bacterial alkaline phosphatase (BAP) and IsoT
were also included in this assay to serve as negative and
positive control, respectively (Fig. 5 h). Collectively, these
results suggest that MCPIP1 deubiquitinase may directly
target the TRAF family, by which it regulates JNK and
NF-B signaling.
MCPIP1 contains a novel DUB domain
The aforementioned results strongly suggest that MCPIP1
functions as a deubiquitinase to control the inflammatory
signal pathways by removing the polyubiquitin moieties from
ubiquitinated TRAFs. DUBs are proteases that cleave ubiquitin chains from protein substrates or their degradation remnants. The human genome encodes 100 DUBs. On the basis
of their domain structures, DUBs can be divided into five
families (Reyes-Turcu et al., 2009). Four are Cys proteases,
including ubiquitin-specific proteases, ubiquitin C-terminal
hydrolases (UCHs), otubain proteases, and Machado-Joseph
disease proteases. The other is a family of metalloproteases.
To determine whether MCPIP1 belongs to any of the five
families, we aligned the MCPIP1 protein sequences with the
five DUB domains. There is no essential sequence similarity
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between MCPIP1 and the five DUB domains except remote
homology with UCH domain (27%), which suggests that
MCPIP1 may contain a novel DUB domain.To find the conserved domains on MCPIP1 protein, we analyzed MCPIP1

sequence by several programs such as Pfam and SMART.
At the N terminus, MCPIP1 contains a ubiquitin association
domain (UBA). In the middle, there is a conserved CCCHtype Zn finger domain (ZF). At the C terminus, MCPIP1

Figure 5. MCPIP1 deubiquitinase targets TRAFs. (a) HEK293 cells were cotransfected with HA-tagged human WT ubiquitin (Ub) with or without
MCPIP1-GFP or Flag-TTP. 24 h later, the cells were treated with TNF for 2 h. TRAF2, TRAF6, RIP, and NEMO were immunoprecipitated (IP) and immuno
blotted (IB) using anti-HA, anti-TRAF2, anti-TRAF6, anti-RIP, or anti-NEMO as indicated. MCPIP1 expression in WCEs was detected using anti-MCPIP1.
IgH, Ig heavy chain. (b) HEK293 cells were cotransfected with HA-ubiquitin, Flag-TRAF2, or Flag-TRAF3 with or without MCPIP1-GFP. 24 h later, the cells were
treated with TNF for 2 h. Lysates were subjected to immunoprecipitation and immunoblot with the indicated antibodies. MCPIP1 expression in WCEs was
detected using anti-MCPIP1. (c) HEK293 cells were cotransfected with HA-ubiquitin with or without MCPIP1-GFP. After 2 h of TNF and MG132 treatment,
the cells were harvested and subjected to immunoprecipitation using IB-specific antibody. The immunoprecipitates were examined by immunoblot
with anti-HA and anti-IB. Data in a–c are representative of at least two independent experiments. (d) Endogenous TRAF2 in the spleens from Mcpip1+/+
and Mcpip1/ mice was immunoprecipitated with anti-TRAF2, followed by immunoblotting with ubiquitin and TRAF2-specific antibodies. Results are
representative of two independent experiments with similar results. (e) Splenocytes from Mcpip1+/+ and Mcpip1/ mice were stimulated with 100 ng/ml
LPS for 30 min. The endogenous TRAF2, TRAF3, TRAF6, and RIP were immunoprecipitated, followed by immunoblotting with antiubiquitin. Results are
representative of two independent experiments with similar results. (f and g) Ubiquitinated purified TRAF2 and TRAF3 were incubated with Flag-MCPIP1
at 37°C for 4 h and analyzed by immunoblotting with anti-HA and anti-Flag. The ubiquitin was tagged with HA. Two independent experiments showed
similar results. (h) HEK293 cells were cotransfected with Flag-TRAF2 with or without HA-ubiquitin. Flag-TRAF2 protein in cell lysates was purified by antiFlag matrix and incubated with 3xFlag buffer only, 0.5 µg Flag-BAP, or 0.5 µg IsoT at 37°C for 4 h and analyzed by immunoblotting with anti-HA.
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contains a Pro-rich domain. By aligning the MCPIP1 sequences from different species, we further identified a conserved region at N terminus (N-terminal conserved region
[NCR]) just preceding CCCH Zn finger and another conserved region at the C terminus (C-terminal conserved region [CCR]; Fig. 6 a).
To examine which domains are functionally important in
deubiquitination, we generated serial truncated constructs of
Flag-tagged MCPIP1 by PCR amplification of the indicated
regions (Fig. 6 a). We cotransfected the truncated plasmids
with HA-ubiquitin into HEK293 cells. Immunoblotting with
HA antibody showed that WT MCPIP1 markedly decreased
overall ubiquitination of cellular proteins. MCPIP1(1–555)
and MCPIP1(81–599), with deletion of the UBA or CCR
without affecting the NCR and Pro-rich domain, maintained
similar deubiquitinating activity as WT MCPIP1. MCPIP1
(1–453), with deletion of the Pro-rich domain, had lower
deubiquitinating activity. MCPIP1(150–599), MCPIP1(150–
453), and MCPIP1(ZF) completely lost deubiquitinating
activity (Fig. 6 b).These results suggest that NCR and CCCH
Zn finger are critical for MCPIP1 deubiquitinating activity.
To further assess whether the repressor activity of MCPIP1
on NF-B reporter is dependent on its deubiquitinating activity, we cotransfected each truncated vector with reporter
construct NF-B–TK-Luc into HEK293 cells. The transfected cells were left untreated or treated with TNF for 24 h,
followed by luciferase assays. As shown in Fig. 6 c, TNF induced NF-B reporter activity by 12-fold. Expression of fulllength MCPIP1 repressed TNF-induced reporter activity
by 80%. MCPIP1(1–555) and MCPIP1(81–599) maintained similar repressing activity as the full-length MCPIP1.
MCPIP1(1–453) had lower repressor activity. MCPIP1(150–
599), MCPIP1(150–453), and MCPIP1(ZF) lost almost all
of the repressor activity. These results suggest that the repressor effect of MCPIP1 on NF-B signaling is dependent on its
deubiquitinating activity.
The aforementioned results suggest that NCR and CCCH
Zn finger may contain a novel DUB domain. As shown in
Fig. 6 d, there are several putative Cys boxes and Asp boxes,
which usually exist in Cys proteases, on the NCR of MCPIP1.
To assess whether these putative boxes constitute the catalytic
domain of MCPIP1 deubiquitinase, we generated serial point
mutants of MCPIP1, as marked by asterisks in Fig. 6 d. The
putative Cys box of MCPIP1 showed 39% sequence homology with that of UCH-L1 and is conserved from fly to human
(Fig. 6 e). Luciferase assay showed that the mutants with
D141N, C157A, D278AD279A, and C306R totally lost the
repressor activity on NF-B reporter (Fig. 6 f). Consistently,
the purified protein with D141N, C157A, and C306R but
not H88A also lost the deubiquitinating activity (Fig. 6 g).
It was recently reported that MCPIP1 also has RNase activity, which targets to the IL-6 3 untranslated region (UTR).
We also measured the RNase activity using these mutant proteins. As shown in Fig. 6 h, MCPIP1 digested the IL-6
3 UTR. Similar to a previous study (Matsushita et al., 2009),
D141N mutant lost the RNase activity. However, H88A,
JEM VOL. 207, December 20, 2010

C157A, and C306R still efficiently digested the transcript.
To further confirm that the repressor effect of MCPIP1 on
inflammatory signaling is dependent on its DUB activity but
not its RNase activity, HEK293 cells were transfected with
control vector, MCPIP1, or its C157A mutant. The transfected
cells were quiescent overnight and stimulated with TNF for 0,
15, and 30 min. As shown in Fig. 6 i, MCPIP1 significantly
suppressed TNF-induced JNK phosphorylation as it did in
other cell lines. C157A mutant, which lost DUB activity but
maintained RNase activity, did not suppress TNF-induced
JNK phosphorylation. Furthermore, ectopic expression of
MCPIP1 in Mcpip1/ MEFs reduced LPS-induced TNF
and MCP-1 release; however, C157A mutant lost the repressor effect (Fig. 6 j). These results suggest that inhibition of
MCPIP1 on JNK and NF-B signaling activation may be
dependent on its DUB activity but not its RNase activity.
MCPIP1 interacts with ubiquitin through its UBA
Ubiquitin-binding domains such as the UBA and ubiquitininteracting motif can influence various cellular events through
binding to ubiquitinated proteins, but the function of ubiquitin-binding domains in the deubiquitination reaction remains
to be elucidated. As shown in Fig. 6 a, MCPIP1 has a putative
UBA at the N terminus. The consensus sequence of UBA in
MCPIP1 is conserved from fly to human (Fig. 7 a). To assess
whether MCPIP1 directly binds to ubiquitin through these
putative UBAs, HEK293 cells were transfected with MCPIP1,
the N-terminal truncated form of MCPIP1 without UBA
(MCPIP1N), or the C-terminal truncated form of MCPIP1
(MCPIP1C; Fig. 7 b). The cell lysates from the transfected
cells were incubated with ubiquitin-agarose, and pull-down
fractions were detected by immunoblotting with Flag antibody.
As shown in Fig. 7 c,WT MCPIP1 was strongly associated with
ubiquitin. MCPIP1C with deletion of the CCR and Pro
region reduced the binding. MCPIP1N with deletion of the
UBA abolished the binding with ubiquitin.These results suggest that MCPIP1 contains a functional UBA and may mediate the association of MCPIP1 with ubiquitinated proteins.
DISCUSSION
MCPIP1 (also known as ZC3H12A) is a prototype member
of a novel CCCH Zn finger–containing protein family, which
was originally identified as an MCP-1–induced gene in human
peripheral monocytes through a DNA microarray (Zhou et al.,
2006). We previously found that MCPIP1 is a negative regulator of proinflammatory activation of macrophages in vitro
(Liang et al., 2008b). Recently, Matsushita et al. (2009) has
identified ZC3H12A/MCPIP1 as an immune response modifier that has an essential role in preventing immune disorder
through generating Zc3h12a KO mice. In this study, we independently developed an Mcpip1/Zc3h12a-null mouse line.
Disruption of Mcpip1 leads to severe inflammatory syndromes,
including growth retardation, splenomegaly, lymphadenopathy, and premature death. In the Mcpip1/ mice, inflammatory cytokines, including TNF and MCP-1, were increased by
>2.5-fold. BMDMs were more sensitive to LPS stimulation.
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Figure 6. MCPIP1 contains a novel DUB domain. (a) The putative functional domains and conserved regions of MCPIP1 and the deletion strategy are
shown. (b) HEK293 cells were cotransfected with HA-ubiquitin (Ub) and with the indicated MCPIP1 constructs. The overall ubiquitination of cellular proteins was examined by immunoblot with HA-specific antibody. Results are representative of at least three independent experiments. (c) The influence of
each MCPIP1 construct on NF-B reporter activity in TNF-stimulated HEK293 cells. Values are expressed as the fold increase in luciferase expression (±SD)
compared with the vector alone (n = 4; *, P < 0.01 vs. MCPIP1(1–599) group). Results are representative of three independent experiments. (d) The putative Asp box and Cys box in the NCR are shown. Point mutants of MCPIP1 were generated as marked with asterisks. (e) Alignment of the Cys region of
MCPIP1 with that from the UCH-L1 DUB domain. The NCBI Protein database accession numbers for human UCH-L1 and MCPIP1 of human, mouse, rat,
zebrafish, and fly are P09936, NP_079355, NP_766373, NP_001071139, XP_001338688, and NP_650863, respectively. Red indicates completely conserved.
Blue indicates mostly conserved. (f) The influence of each MCPIP1 construct on NF-B reporter activity in TNF-stimulated HEK293 cells. Values are expressed as the fold increase in luciferase expression (±SD) compared with the vector alone (n = 4; *, P < 0.01 vs. MCPIP1 WT group). Results are representative of three independent experiments. The expression of each construct was detected by immunoblot (IB) with anti-Flag antibody as shown.
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Figure 7. MCPIP1 interacts with ubiquitin through the UBA at the N terminus. (a) The alignment of the putative UBA of MCPIP1 proteins from
human, mouse, rat, zebrafish, and fly with UBA consensus sequence. Red indicates completely conserved amino acids. Blue indicates partially conserved
amino acids. (b) HEK293 cells were transfected with Flag-tagged MCPIP1 and its C-terminal or N-terminal truncated mutants as indicated. (c) The cell
lysates from transfected cells were incubated with ubiquitin-agarose and washed and analyzed by immunoblot with anti-Flag (pull-down). Input levels of
each construct in the cell lysates were examined by immunoblot with anti-Flag. Results are representative of two independent experiments.

These results further support the idea that Mcpip1/Zc3h12a
is a critical modulator of inflammatory response and immune
homeostasis. How does MCPIP1 regulate inflammatory response? Two groups recently reported that MCPIP1 might be
functioning as an RNase to promote the degradation of some
inflammatory mRNA such as IL-6 and IL-1 (Matsushita et al.,
2009; Mizgalska et al., 2009). In this study, we have found that
MCPIP1 also acts as a deubiquitinase to negatively regulate
JNK and NF-B signaling by targeting TRAFs, which suggests that MCPIP1 may control inflammatory response and
immune homeostasis by multiple mechanisms. Interestingly,
TTP, another well-studied CCCH Zn finger–containing
protein and a well-known RNA-destabilizing factor, was also
reported to regulate NF-B signaling (Liang et al., 2009; Schichl
et al., 2009).
Ubiquitination is a fundamental mechanism of signal
transduction that regulates immune responses and many other
biological processes (Sun, 2008). Similar to phosphorylation,
ubiquitination is a reversible process that is counter-regulated
by DUBs. Several DUBs such as CYLD, A20, DUBA, and
Cezanne are involved in the regulation of inflammatory signaling in macrophages and immune cells (Evans et al., 2003;
Reiley et al., 2004; Wertz et al., 2004; Kayagaki et al., 2007).
In contrast to CYLD and DUBA, which attenuate NF-B

and JNK signaling by selectively removing K63-linked polyubiquitin chains from TRAFs, RIP, and NEMO, MCPIP1
also cleaves K48-linked polyubiquitin chains in vitro. Another
difference is that CYLD does not affect the global cellular
ubiquitination. However, MCPIP1 markedly affects the overall
ubiquitination of cellular proteins, which implies that MCPIP1
may target more substrates and regulate multiple biological
processes that need to be further identified. As evidence,
MCPIP1/ mice showed much more complicated and severe phenotypes than CYLD mutated mice (Jin et al., 2008).
The direct targets of MCPIP1 deubiquitinase in vivo are
still uncertain.We observed that the ubiquitination of TRAF2,
TRAF3, TRAF6, RIP, and IB was significantly decreased
by MCPIP1 expression. Moreover, loss of Mcpip1 led to a drastic
increase in basal and LPS-induced ubiquitination of TRAF2,
TRAF3, and TRAF6 but not RIP. Because TRAF2 and TRAF6
are upstream effectors of RIP and IB, the ubiquitination
changes of RIP and IB caused by MCPIP1 expression may
be indirect. MCPIP1 deubiquitinase may directly target to
TRAF family members and regulate JNK and NF-B signaling. At least we showed that the purified cellular ubiquitinated
TRAF2 and TRAF3 can also be cleaved by MCPIP1 purified
protein in vitro. Nevertheless, the direct targets of MCPIP1
deubiquitinase in vivo need to be further characterized.

(g) Flag-tagged MCPIP1 proteins were purified from HEK293 cells and incubated with K63-linked Ub6 at 37°C for 16 h. The reactions were examined by
immunoblotting with ubiquitin-specific antibody. The images of Coomassie blue–stained protein gel and immunoblot with anti-Flag are shown at the
bottom. Results are representative of three independent experiments. HMUb, high molecular weight ubiquitin. (h) Flag-tagged MCPIP1 proteins were
incubated with 32P-labeled transcripts from the IL-6 3 UTR at 30°C for 7 h. Samples were run on a 6% polyacrylamide–6M urea gel. The gels were dried
and autoradiographed. The proteins loaded were detected by immunoblotting with anti-Flag as shown on the bottom. Two independent experiments
showed similar results. (f–h) Vertical black lines indicate that intervening lanes have been spliced out. (i) HEK293 cells were transfected with control vector, Flag-MCPIP1, or Flag-C157A. After 24 h, the transfected cells were quiescent for 16 h and then stimulated with 100 ng/ml LPS for the indicated times.
WCEs were subjected to immunoblot analysis with the antibodies as indicated. Two independent experiments showed similar results. (j) Mcpip1/ MEFs
were transfected with Flag-MCPIP1 or Flag-C157A. After 24 h, the transfected cells and untransfected MEFs were stimulated with LPS for 5 h. TNF and
MCP-1 in medium were measured by ELISA. Data are represented as mean ± SD (n = 3; *, P < 0.01). The expression of MCPIP1 constructs was detected by
immunoblotting with anti-Flag as shown on the bottom.
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MCPIP1 may selectively regulate different signal pathways. As shown in our results, MCPIP1 is a potent suppressor
of both LPS- and IL-1–induced JNK activation. However,
MCPIP1 just moderately affects LPS-induced IKK activation
but does not affect IL-1–induced IKK activation. This is
consistent with the other observation that ubc13, a unique E2
for K63-linked ubiquitination, is essential for JNK activation
but not critical for NF-B activation (Yamamoto et al., 2006).
Interestingly, overexpression of MCPIP1 potently suppresses
LPS- and cytokine-induced NF-B–dependent reporter activity. It suggests that MCPIP1 may also target the downstream
effectors of NF-B signaling. Matsushita et al. (2009) did not
find any difference between Mcpip1/ and Mcpip1+/+ mice
with respect to LPS-induced NF-B and AP-1 activation in
peritoneal macrophages.The reason for this discrepancy is not
yet known but may be caused by the different cell types used.
In the lung from Mcpip1/ mice, both JNK and IKK were
constitutively activated. However, JNK and IKK in BMDMs
were not constitutively activated; instead, their activation was
enhanced by LPS stimulation. The reason for this difference
may be because there are many mature macrophages in the
lung and these macrophages are exposed to the air.
The human genome encodes almost 100 DUBs (Nijman
et al., 2005). Based on their domain structures, these DUBs
can be divided into five families: UCHs, ubiquitin-specific
proteases, otubain proteases, Machado-Joseph disease proteases, and JAB1/PAB1/MPN domain–containing metalloenzymes. Each contains specific but conserved DUB domains.
MCPIP1 does not belong to any of the five known families
as it does not contain any of the five specific domains based
on sequence alignment. However, we characterized the NCR
containing intrinsic deubiquitinating activity, which has remote sequence homology to the UCH domain (27%). In addition, MCPIP1 contains two conserved sequence motifs, the
Cys and Asp boxes, in its catalytic domain, which is common
in Cys proteases. Mutation of several histidines did not impair
the deubiquitinating activity, suggesting that the His box may
be located outside of the NCR or that MCPIP1 lacks the His
box as does CYLD. Some of the biochemical characteristics
of DUB of MCPIP1 are similar to other DUBs. Its deubiquitinating activity can be completely abolished by NEM, a Cys
protease inhibitor, which is consistent with MCPIP1 being
a Cys protease. In addition, the deubiquitinating activity of
MCPIP1 is not dependent on Mg2+ and ATP but is inhibited
by Zn2+ and Mn2+, as reported for another DUB (Matsui et al.,
1982). Thus, MCPIP1 may represent a member of a novel
DUB family.
It was recently reported that MCPIP1 has RNase activity
and may control immune response through regulating inflammatory mRNA decay (Matsushita et al., 2009). In this
study, we provide evidence that MCPIP1 also acts as a DUB
to negatively regulate inflammatory signaling. By deletion
experiments, MCPIP1 deubiquitinase domain has also been
mapped on NCR regions as its RNase domain. However, serial mutagenesis showed that Asp141, Cys157, and Cys306 in
the Asp box, Cys box, and CCCH Zn finger, respectively, are
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critically important for its DUB activity. Although Asp141 is
also important for its RNase activity, mutation of two other
amino acids, C157A and C306R, that abolished DUB activity
did not affect its RNase activity. In an NF-B reporter assay,
the D141, C157, C306, and D278/D279 mutants resulted in
the loss of MCPIP1 repressor activity on NF-B–dependent
reporter activation. Furthermore, C157A mutant, which lost
DUB activity but maintained RNase activity, also lost repressor effect on JNK activation and LPS-induced inflammatory
cytokine production. These results suggest that the inhibition
of MCPIP1 on inflammatory signaling is dependent on its
DUB activity. The relationship between the two enzymatic
activities is under investigation.
There are many interesting questions that remain to be
answered. How does MCPIP1 protein target to specific substrates in response to environmental cues? We postulate that
the specific adaptor proteins may recruit MCPIP1 to different
substrates and exert different functions: degrading mRNA or
cleaving polyubiquitin. In fact, MCPIP1 contains a single
conserved CCCH ZF and a Pro-rich domain, which may
mediate the interaction with adaptor proteins. There is also a
functional UBA at the N terminus of MCPIP1. MCPIP1
may interact with ubiquitinated protein through this domain.
However, N-terminal truncation of MCPIP1 without this
UBA also decreased protein ubiquitination in cells as WT
MCPIP1, suggesting that this UBA may not be required for
its DUB activity in vivo. MCPIP1 may also bind to its substrates through other means. Nevertheless, identification of
the binding partners of MCPIP1 will greatly enhance our
understanding of MCPIP1 functions. In addition, it would be
interesting to find out the function of the other three members of the MCPIP1 family. In summary, we here identified
MCPIP1 as a deubiquitinase that negatively regulates JNK
and NF-B signaling by targeting TRAFs and defined a novel
DUB domain, which suggests that MCPIP1 may control inflammation and immune response by multiple mechanisms
and would be a potential therapeutic target for treatment of
human inflammatory diseases.
MATERIALS AND METHODS
Generation of Mcpip1/ mice. The Mcpip1 targeting construct was built
using the pN-Z-TK2 vector, which contains a nuclear LacZ cassette and a
neomycin-resistance gene (provided by R. Palmiter, University of Washington,
Seattle, WA). The 4.2-kb 5 arm and 2.7-kb 3 arm were amplified by PCR
using a BacPac vector (RP23-262L9) as template, which was from C57BL/6
mice and contained the Mcpip1 gene. The amplified DNA fragments were
confirmed by sequencing and inserted upstream and downstream of the
nuclear LacZ-Neo cassette by KpnI–SalI and XhoI–NotI, respectively. The
targeting construct was linearized and electroporated into C57BL/6-derived
embryonic stem cells (inGenious Targeting Laboratory, Inc.). After selection
with G418, drug-resistant clones were picked up and screened by PCR and
Southern blot analysis. Two Mcpip1-targeted embryonic stem clones were
individually microinjected into blastocysts derived from C57BL/6 mice and
transferred to pseudopregnant females. The resulting chimeric mice were
bred to C57BL/6 to obtain germline transmission of the mutant allele.
Resulting Mcpip1+/ mice were intercrossed to generate Mcpip1/ mice. All
animal experiments were performed with the approval of the institutional
animal care and use committee at the University of Central Florida.
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Cells. The mouse macrophage cell line RAW264.7 was obtained from the
American Type Culture Collection and maintained in RPMI 1640 supplemented with 2 mM Gln, 100 U/ml penicillin and streptomycin, and 10%
FBS (endotoxin <1 ng/ml; Sigma-Aldrich). HEK293 cells were cultured in
DME supplemented with 2 mM Gln, 100 U/ml penicillin and streptomycin,
and 10% FBS. Mouse BMDMs were generated from BM stem cells obtained
from femurs of the male Mcpip1+/+ and Mcpip1/ mice (6 wk old). After lysis
of the red blood cells, 4 × 106 of BM stem cells were inoculated in a 6-well
plate with complete DME culture medium containing 10% FBS, 30%
L-medium, and standard supplements. After 5-d culture, the fully differentiated
and matured BMDMs were quiescent for 24 h in macrophage serum-free
medium and then treated with 100 ng/ml LPS for different time points.
Plasmids. NF-B–TK-Luc, AP-1–TK-Luc, and GAS-TK-Luc were purchased from Agilent Technologies. Flag-TRAF2 plasmid was provided by
Y. Sun (University of Michigan, Ann Arbor, MI). Flag-TRAF3 plasmid was
provided by G. Chen (University of California, Los Angeles, Los Angeles, CA).
Flag-TTP was provided by J. Lykke-Andersen (University of California,
San Diego, La Jolla, CA). HA-ubiquitin was obtained through Addgene from
T. Dawson (Johns Hopkins University, Baltimore, MD). MCPIP1-GFP
plasmid was described previously (Zhou et al., 2006; Liang et al., 2008b).
HA-tagged MCPIP1 expression plasmid was generated by inserting human
MCPIP1 coding fragment into pcDNA3-HA vector at EcoRI and XbaI
sites. Flag-tagged MCPIP1 expression plasmid was generated by inserting
human MCPIP1 coding fragment into pCMV-MAT-Tag-Flag-1 vector
(Sigma-Aldrich) at HindIII and BamHI sites. MCPIP1 serial deletion plasmids were generated by inserting the PCR-amplified fragments into pCMVMAT-Tag-Flag-1 vector at EcoRI and XbaI sites. MCPIP1ZF plasmid was
generated by mutating K311C312 into GG using Flag-MCPIP1 as template.
MCPIP1 serial point mutants were generated using the QuikChange II SiteDirected Mutagenesis kit (Agilent Technologies) using Flag-MCPIP1 as
template. IL-6 3 UTR (1–403) was amplified by PCR and inserted into
pCR-Blunt II-TOPO (Invitrogen).
Reagents. The MCPIP1 rabbit polyclonal antibody was prepared against the
human recombinant MCPIP1 protein as described previously (Zhou et al.,
2006; Liang et al., 2008b). Except antiubiquitin antibody from Boston Biochem, all other antibodies used in this paper were purchased from Cell Signaling Technology. Anti-Flag M2 affinity gel, anti-HA immunoprecipitation
kit, protein G immunoprecipitation kit, LPS (Escherichia coli 026:B6-derived),
human recombinant IFN-, IL-1, and TNF, NEM, and other chemical reagents were purchased from Sigma-Aldrich. Ubiquitin chains, ubiquitinAFC, ubiquitin-agarose, IsoT, ubiquitin aldehyde, and MG132 were purchased
from Boston Biochem. Purified Flag-BAP, an N-terminal Flag fusion protein
of E. coli BAP, was purchased from Sigma-Aldrich.
Transient transfection and luciferase assay. Transfection and luciferase
assay were performed as described previously (Liang et al., 2008b). All transfections were performed in triplicate and repeated at least two times.
Protein isolation and immunoblotting. Protein isolation and immunoblotting were essentially performed as described previously (Liang et al.,
2008b). To facilitate the detection of the phosphorylated or ubiquitinated
proteins in cell lysates, radioimmunoprecipitation assay (RIPA) buffer was
added with protease inhibitor cocktails (Sigma-Aldrich), phosphatase cocktail I and II (Sigma-Aldrich), 20 µM NEM, and 2 µM ubiquitin aldehyde.
Coimmunoprecipitation. For endogenous immunoprecipitations, the
transfected HEK293 cells were lysed in CelLytic M Cell lysis buffer with
protease inhibitors, phosphatase inhibitors, NEM, and ubiquitin aldehyde.
Lysates were incubated with specific antibodies. The immune complexes
were collected by incubation (2 h at 4°C) with protein G–agarose (SigmaAldrich). Coimmunoprecipitation assays were performed by using anti-Flag
matrix (Sigma-Aldrich) according to the manufacturer’s instruction. After
extensive washing, immunoprecipitated proteins were resolved by 6–10%
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SDS-PAGE and analyzed by immunoblotting with Flag, HA, or MCPIP1
antibodies. Membranes were developed with enhanced chemiluminescence
(GE Healthcare).
RNA isolation, RNA blot, and quantitative PCR (QPCR). Total
RNA was isolated from cells or tissues using RNA STAT-60 reagent (TelTest, Inc.) according to the manufacturer’s instruction. RNA blot and QPCR
were performed as described previously (Liang et al., 2008b).
In vivo deubiquitination assay. HEK293 cells were transfected with HAubiquitin as well as other plasmids as indicated. 24 h later, cells were stimulated with TNF for 2 h, and the cells were harvested using RIPA buffer
(Thermo Fisher Scientific) containing protease inhibitor cocktail, 20 µM
NEM, and 2 µM ubiquitin aldehyde. The whole cell extracts (WCEs) were
directly subjected to immunoblot analysis with HA antibody or further immunoprecipitated using specific antibodies as indicated and then analyzed by
immunoblot with HA antibody.
Purification of Flag-MCPIP1 and its mutant proteins. Flag-MCPIP1
or its mutants were transfected into HEK293 cells individually. 48 h later, the
transfected cells were harvested using RIPA buffer containing protease inhibitor cocktail. The cell lysates were incubated with Flag M2 beads (SigmaAldrich) overnight with rotation at 4°C. After washing three times, the
Flag-MCPIP1 was eluted by 3xFlag elution buffer.
Cell-free deubiquitination assay. 0.5 µg K48- or K63-linked ubiquitin
chains (Boston Biochem) were mixed with purified Flag-MCPIP1 or its mutant
proteins in DUB assay buffer (50 mM Hepes-NaOH, pH 8.0, 10% glycerol,
and 3 mM DTT) at 37°C for 16 h or the indicated times. Samples were prepared for immunoblot analysis with ubiquitin antibody (Boston Biochem).
In vitro cleavage assay of cellular ubiquitinated TRAFs. Flag-TRAF2
or Flag-TRAF3 was cotransfected with HA-ubiquitin into HEK293 cells. 24 h
later, the transfected cells were stimulated with TNF for 15 min. The cells
were harvested using RIPA buffer containing protease inhibitor cocktail and
NEM. The cell lysates were incubated with Flag M2 beads overnight with
rotation at 4°C. After washing three times with TBS buffer, Flag-TRAF2 or
Flag-TRAF3 was eluted by 3xFlag elution buffer. 15 µl of eluted FlagTRAF2 or Flag-TRAF3 was incubated with purified Flag-MCPIP1 in
DUB assay buffer at 37°C for 4 h. Samples were prepared for immunoblot
analysis with HA and Flag antibodies.
In vitro RNA cleavage assay. The pTOPO–IL-6 3 UTR (1–430) plasmid was used as a template for the synthesis of RNA having an IL-6 3 UTR
sequence. In vitro RNA synthesis and 32P labeling were performed using the
Riboprobe in vitro transcription system (Promega) according to the manufacturer’s instructions. Equal amounts of in vitro transcribed 32P-labeled
RNAs (5,000 cpm) were incubated with 2 µg MCPIP1 or its mutants at
30°C for 7 h in 25 mM Hepes, pH 8.0, 50 mM potassium acetate, 5 mM
DTT, and 5 mM Mg acetate. The cleaved RNA was purified with TRIZOL
(Invitrogen). Samples were run on a 6% polyacrylamide–6M urea gel in 1× Tris/
Borate/EDTA buffer after RNA sample buffer and loading buffer were added
to the samples, and samples were heated at 80°C for 10 min according to the
manufacturer’s recommendations. Gels were dried and autoradiographed.
Ubiquitin chain binding assay. Flag-MCPIP1 and its mutant proteins
purified from HEK293 cells were incubated with ubiquitin-agarose (Boston
Biochem) in 50 mM Tris-HCI, pH 7.5, 150 mM NaCl, and 1% Triton buffer
overnight at 4°C. Immunoprecipitants were washed with the same buffer for
three times and subjected to immunoblot analysis with Flag antibody.
Statistics. Data were expressed as mean ± SD. For comparison between two
groups, the unpaired Student’s t test was used. For multiple comparisons,
analysis of variance followed by unpaired Student’s t test was used. A value of
P < 0.05 was considered significant.
2971

Online supplemental material. Fig. S1 shows the tissue distribution of
Mcpip1 mRNA in mice. Fig. S2 shows the relative mRNA levels of inflammatory genes, including TNF, IL-6, IL-1, and iNOS, in intestine, lung, and
thymus from Mcpip1+/+ and Mcpip1/ mice. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20092641/DC1.
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